IMC Chicago
TGTX icon

IMC Chicago’s TG Therapeutics TGTX Stock Holding History

IMC Chicago’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.62M Buy
108,900
+27,600
+34% +$823K ﹤0.01% 2066
2025
Q4 		$2.42M Sell
81,300
-26,000
-24% -$849K ﹤0.01% 2257
2025
Q3 		$3.88M Sell
107,300
-48,300
-31% -$1.59M ﹤0.01% 1749
2025
Q2 		$5.6M Buy
155,600
+34,700
+29% +$1.29M ﹤0.01% 1319
2025
Q1 		$4.77M Sell
120,900
-13,600
-10% -$458K ﹤0.01% 1253
2024
Q4 		$4.05M Buy
134,500
+103,800
+338% +$2.98M ﹤0.01% 1375
2024
Q3 		$718K Sell
30,700
-7,400
-19% -$162K ﹤0.01% 2224
2024
Q2 		$678K Sell
38,100
-13,000
-25% -$207K ﹤0.01% 2173
2024
Q1 		$777K Buy
51,100
+16,300
+47% +$260K ﹤0.01% 1846
2023
Q4 		$594K Buy
+34,800
New +$404K ﹤0.01% 1594

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

IMC Chicago's TGTX Position: Q4 2025 in Review

IMC Chicago sold out of TG Therapeutics (TGTX) in Q4 2025, closing a stake of 22,903 shares — an estimated $748K sold.

IMC Chicago first reported a position in TGTX in Q4 2023 and held it in 4 quarters. The position peaked at $1M in Q2 2025. 351 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • IMC Chicago reported no remaining TG Therapeutics position as of Q4 2025 after selling out during the quarter.
  • IMC Chicago sold 22,903 TG Therapeutics shares in Q4 2025, an estimated $748K.
  • IMC Chicago first reported a position in TG Therapeutics in Q4 2023 and held it in 4 quarters.
  • IMC Chicago's TG Therapeutics position peaked at $1M in Q2 2025.
  • 351 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.